Skip to main content

RPGLIFE · RPG Life Sciences Limited · Documents

2,551.45 INR -27.55 (-1.07%) At close · Nov 13
Volume · Nov 13 386 Avg daily vol (3M) 1353

The company's reports, filings, earnings calls and investor events, most recent first. Search these from Claude or ChatGPT →

Earnings call Q2 2027 earnings call Held Oct 30, 2026
2026
Oct 30
Earnings call
Revenue tops 200 crore as adjusted EBITDA reaches 50.1 crore

RPG Life Sciences Limited reported quarterly revenue above 200 crore and adjusted EBITDA of 50.1 crore; H1 revenue reached 407.3 crore, up 16.2%, while completing API acquisitions.

5 source passages
RPG Life Sciences has a legacy for more than five decades. For the first time, we crossed 200 crore in quarterly revenue and 50 crore in quarterly EBITDA. With our adjusted EBITDA, excluding one-time restructuring and API acquisition link cost of 5.5 crore, we grew 15% to 50.1 crore in quarter two versus 43.6 crore last year. For the first half, revenue growth grew 16.2% to 407.3, crossing the 400 crore mark for a half year. All three of our business grew, and in parallel, we completed the most significant strategic step in the history of our API business with the creation of RPG Active Pharma and the acquisitions of Actives and Ragwa. Open the document at this passage
Showing 1–1 of 1 documents